Lung clearance index: Evidence for use in clinical trials in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 13, Issue 2, 2014, Pages 123-138

  Kent, L ^a,b   Reix, P ^c   Innes, J A ^d,e   Zielen, S ^f   Le Bourgeois, M ^g   Braggion, C ^h   Lever, S ⁱ   Arets, H G M ^j   Brownlee, K ^k   Bradley, J M ^a,b   Bayfield, K ^l   O'Neill, K ^m   Savi, D ⁿ   Bilton, D ^o   Lindblad, A ^p   Davies, J C ^l,o   Sermet, I ^g,q   De Boeck, K ^r  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^c HOSPICES CIVILS DE LYON   (France)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f GOETHE UNIVERSITY   (Germany)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

ⁿ SAPIENZA UNIVERSITY OF ROME   (Italy)

^o ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^p QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^q UNIVERSITÉ PARIS DESCARTES   (France)

^r UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

Clinimetric properties; Lung clearance index; Multiple breath washout; Outcome measures; Surrogate endpoints

Indexed keywords

BIOLOGICAL MARKER;

BREATH ANALYSIS; CYSTIC FIBROSIS; FEASIBILITY STUDY; HUMAN; LUNG FUNCTION TEST; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STANDARDS;

BIOLOGICAL MARKERS; BREATH TESTS; CYSTIC FIBROSIS; FEASIBILITY STUDIES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84895069609     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.09.005     Document Type: Review

References (67)

1. De Boeck K., Kent L., Davies J., Derichs N., Amaral M., Rowe S., et al. CFTR biomarkers: time for promotion to surrogate endpoint?. Eur Respir J 2013, 41(1):203-216.
2. De Gruttola V.G., Clax P., DeMets D.L., Downing G.J., Ellenberg S.S., Friedman L., et al. Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control Clin Trials 2001, 22(5):485-502.
3. Atkinson A.J., Colburn W.A., DeGruttola V.G., DeMets D.L., Downing G.J., Hoth D.F., et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69(3):89-95.
4. Liou T.G., Elkin E.P., Pasta D.J., Jacobs J.R., Konstan M.W., Morgan W.J., et al. Year-to-year changes in lung function in individuals with cystic fibrosis. J Cyst Fibros 2010, 9(2):250-256.
5. Fuchs S.I., Gappa M. Lung clearance index: clinical and research applications in children. Paediatr Respir Rev 2011, 12(4):264-270.
6. Stocks J., Thia L.P., Sonnappa S. Evaluation and use of childhood lung function tests in cystic fibrosis. Curr Opin Pulm Med 2012, 18(6):602-608.
7. Robinson P.D., Goldman M.D., Gustaffson P.M. Inert gas washout: theoretical background and clinical utility in respiratory disease. Respiration 2009, 78:339-355.
8. Aurora P., Kozlowska W., Stocks J. Gas mixing efficiency from birth to adulthood measured by multiple-breath washout. Respir Physiol Neurobiol 2005, 148:125-139.
9. Davies J.C., Sheridan H., Lee P.-S., Song T., Stone A., Ratjen F. Effect of ivacaftor on lung function in subjects with CF who have the G551D-CFTR mutation and mild lung disease: a comparison of lung clearance index (LCI) vs. spirometry. J Cyst Fibros 2012, 11(Suppl. 1):S15.
10. Amin R., Subbarao P., Jabar A., Balkovec S., Jensen R., Kerrigan S., et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010, 65:379-383.
11. Amin R., Subbarao P., Lou W., Jabar A., Balkovec S., Jensen R., et al. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 2011, 37:806-812.
12. Subbarao P., Stanojevic S., Brown M., Jensen R., McDonald N., Gent K., et al. Effect of hypertonic saline on lung clearance index in infants and preschool children with CF: a pilot study. Pediatr Pulmonol 2012, 47(Suppl. 35):223.
13. Singer F., Houltz B., Latzin P., Robinson P.D., Gustafsson P. A realistic validation study of a new nitrogen multiple-breath washout system. PLoS One 2012, 7(4):e36083.
14. Robinson P., Latzin P., Verbanck S., Hall G.L., Horsley A.R., Gappa M., et al. Consensus statement for inert gas washout measurement using multiple and single breath tests. Eur Respir J 2013, 41(3):507-522.
15. Jensen R., Stanojevic S., Gibney K., Salazar J.G., Gustafsson P.M., Subbarao P., et al. Multiple breath nitrogen washout: a feasible alternative to mass spectrometry. PLoS One 2013, 8(2):e56868.
16. Horsley A.R., Macleod K.A., Robson A.G., Lenney J., Bell N.J., Cunningham S., et al. Effects of cystic fibrosis lung disease on gas mixing indices derived from alveolar slope analysis. Respir Physiol Neurobiol 2008, 162:197-203.
17. Verbanck S., Paiva M., Paeps E., Schuermans D., Malfroot A., Vinvken W., et al. Lung clearance index in adult CF patients: the role of convection-dependent lung units. Eur Respir J 2013, 42(2):380-388. 10.1183/09031936.00125312.
18. Horsley A.R., Gustaffson P.M., Macleod K.A., Saunders C., Greening A.P., Porteous D.J., et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008, 63:135-140.
19. Gustafsson P.M. Peripheral airway involvement in CF and asthma compared by inert gas washout. Pediatr Pulmonol 2007, 42:168-176.
20. Fuchs S.I., Ellemunter H., Eder J., Mellies U., Grosse-Onnebrink J., Tummler B., et al. Feasibility and variability of measuring the lung clearance index in a multi-centre setting. Pediatr Pulmonol 2012, 47(7):649-657.
21. Hoo A., Thia L.P., Nguyen T.T.D., Bush A., Chudleigh J., Lum S., et al. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012, 67:874-881.
22. Belessis Y., Dixon B., Hawkins G., Pereira J., Peat J., MacDonald R., et al. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med 2012, 185(8):862-873.
23. Lum S., Gustafsson P.M., Ljungberg H., Hülskamp G., Bush A., Carr S., et al. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax 2007, 62:341-347.
24. Haidopoulou K., Lum S., Turcu S., Guinard C., Aurora P., Stocks J., et al. Alveolar LCI vs. standard LCI in detecting early CF lung disease. Respir Physiol Neurobiol 2012, 180:247-251.
25. Owens C.M., Aurora P., Stanojevic S., Bush A., Wade A., Oliver C., et al. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011, 66:481-488.
26. Gustafsson P.M., Aurora P., Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003, 22:972-979.
27. Hall G.L., Logie K.M., Parsons F., Schulzke S.M., Nolan G., Murray C., et al. Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening. PLoS One 2011, 6(8):e23932.
28. Gustafsson P.M., De Jong P.A., Tiddens H.A.W.M., Lindblad A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008, 63:129-134.
29. Ellemunter H., Fuchs S.I., Unsinn K.M., Freund M.C., Waltner-Romen M., Steinkamp G., et al. Sensitivity of lung clearance index and chest computed tomography in early CF lung disease. Respir Med 2010, 104:1834-1842.
30. Aurora P., Gustafsson P.M., Bush A., Lindblad A., Oliver C., Wallis C.E., et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004, 59:1068-1073.
31. Fuchs S.I., Sturz J., Junge S., Ballman M., Gappa M. A novel sidestream ultrasonic flow sensor for multiple breath washout in children. Pediatr Pulmonol 2008, 43:731-738.
32. Singer F., Kieninger E., Abbas C., Yammine S., Fuchs O., Proietti E., et al. Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting. Pediatr Pulmonol 2013, 48(8):739-746. 10.1002/ppul.22651.
33. Aurora P., Bush A., Gustafsson P.M., Oliver C., Wallis C., Price J., et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:249-256.
34. Gustafsson P.M., Kallman S., Ljungberg H., Lindblad A. Method for assessment of volume of trapped gas in infants during multiple-breath inert gas washout. Pediatr Pulmonol 2003, 35:42-49.
35. Aurora P., Stanojevic S., Wade A., Oliver C., Kozlowska W., Lum S., et al. Lung clearance index at 4years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2011, 183:752-758.
36. Robinson P.D., Cooper P., Van Asperen P., Fitzgerald D., Selvadurai H. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol 2009, 44:733-742.
37. Horsley A.R., Davies J.C., Gray R.D., Macleod K.A., Donovan J., Aziz Z.A., et al. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 2013, 68(6):532-539.
38. 2 washout ventilation inhomogeneity indices in a reference population aged 7-70years 2012, European Respiratory Society.
39. Sonnappa S., Bastardo C.M., Wade A., Bush A., Stocks J., Aurora P. Repeatability and bronchodilator reversibility of lung function in young children. Eur Respir J 2013, [online ahead of print].
40. Keen C. Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis. Pediatr Pulmonol 2010, 45:241-248.
41. Pittman J.E., et al. Variability of a closed, rebreathing setup for multiple breath wash-out testing in children. Pediatr Pulmonol 2012, 47:1242-1250.
42. Fuchs S.I., et al. Calculation of the capnographic index based on expiratory molar mass-volume-curves: a suitable tool to screen for cystic fibrosis lung disease. J Cyst Fibros 2012, 12(3):277-283.
43. Bakker E.M., et al. Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency. J Cyst Fibros 2012, 11(3):223-230.
44. Kraemer R., et al. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis. Respir Res 2006, 7:138.
45. Kraemer R., et al. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:371-378.
46. Kraemer R., et al. Long-term gas exchange characteristics as markers of deterioration in patients with cystic fibrosis. Respir Res 2009, 10:106.
47. Fuchs S.I., et al. Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis. Pediatr Pulmonol 2010, 45:301-306.
48. Kieninger E., et al. Long-term course of lung clearance index between infancy and school-age in cystic fibrosis subjects. J Cyst Fibros 2011, 10(6):487-490.
49. Sinhal S., et al. Reproducibility of multiple breath washout indices in the unsedated preterm neonate. Pediatr Pulmonol 2010, 45:62-70.
50. Hülskamp G., et al. Association of prematurity, lung disease and body size with lung volume and ventilation inhomogeneity in unsedated neonates: a multicentre study. Thorax 2009, 64:240-245.
51. Riedel T., et al. Regional and overall ventilation inhomogeneities in preterm and term-born infants. Intensive Care Med 2009, 35:144-151.
52. Schulzke S.M., et al. Nasal versus face mask for multiple-breath washout technique in preterm infants. Pediatr Pulmonol 2008, 43:858-865.
53. Latzin P., et al. Lung volume, breathing pattern and ventilation inhomogeneity in preterm and term infants. PLoS One 2009, 4(2):e4635.
54. Fuchs S.I., et al. Multiple breath washout with a sidestream ultrasonic flow sensor and mass spectrometry: a comparative study. Pediatr Pulmonol 2006, 41:1218-1225.
55. Riedel T., Richards T., Schibler A. The value of electrical impedance tomography in assessing the effect of body position and positive airway pressures on regional lung ventilation in spontaneously breathing subjects. Intensive Care Med 2005, 31:1522-1528.
56. Fuchs S.I., et al. Lung clearance index: normal values, repeatability, and reproducibility in healthy children and adolescents. Pediatr Pulmonol 2009, 44:1180-1185.
57. Macleod K.A., et al. Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease. Thorax 2009, 64:33-37.
58. Sonnappa S., et al. Symptom-pattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol 2010, 126:519-526.
59. Gronkvist M., Bergsten E., Gustafsson P. Effects of body posture and tidal volume on inter- and intraregional ventilation distribution in healthy men. J Appl Physiol 2002, 92:634-642.
60. Shao H., et al. Moment analysis of multibreath nitrogen washout in healthy preterm infants. Pediatr Pulmonol 1998, 25:52-58.
61. Hjalmarson O., Sandberg K. Abnormal lung function in healthy preterm infants. Am J Respir Crit Care Med 2002, 165:83-87.
62. Verbanck S., et al. Ventilation heterogeneity in the acinar and conductive zones of the normal ageing lung. Thorax 2013, [in press].
63. Downie S., et al. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax 2007, 62:684-689.
64. Arborelius M., Rosberg H.E., Wiberg R. Multiple breath nitrogen dead space. Clin Physiol 1988, 8:561-576.
65. Chakr V.C., et al. Ventilation homogeneity improves with growth early in life. Pediatr Pulmonol 2011.
66. Aljassim F., et al. A whisper from the silent lung zone. Pediatr Pulmonol 2009, 44:829-832.
67. Davis S.D., et al. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 2010, 182(11):1387-1397.